OC
GMDA

Oppenheimer & Co’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Oppenheimer & Co’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,800
Closed -$69K – 1597
2021
Q2 		$69K Hold
10,800
– – ﹤0.01% 1481
2021
Q1 		$87K Buy
+10,800
New +$99.1K ﹤0.01% 1405

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Oppenheimer & Co's GMDA Position: Q3 2021 in Review

Oppenheimer & Co sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2021, closing a stake of 10,800 shares — an estimated $69K sold.

Oppenheimer & Co first reported a position in GMDA in Q1 2021 and held it in 2 quarters. The position peaked at $87K in Q1 2021. 73 funds tracked by Wall St. Rank hold GMDA as of Q3 2021.

  • Oppenheimer & Co reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 10,800 Gamida Cell Ltd. Ordinary Shares shares in Q3 2021, an estimated $69K.
  • Oppenheimer & Co first reported a position in Gamida Cell Ltd. Ordinary Shares in Q1 2021 and held it in 2 quarters.
  • Oppenheimer & Co's Gamida Cell Ltd. Ordinary Shares position peaked at $87K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2021.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.